Am J Pharm Benefits. 2014;6(1):e1-e8.
Vitamin D Deficiency Treatment Patterns in Academic Urban Medical Center.
The American journal of pharmacy benefits
Paulette D Chandler, Edward L Giovannucci, Michelle A Williams, Meryl S LeBoff, David W Bates, LeRoi S Hicks
Affiliations
Affiliations
- Division of General Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA ; Harvard Medical School, Boston, MA.
- Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA ; Harvard Medical School, Boston, MA.
- Harvard Medical School, Boston, MA ; Harvard School of Public Health, Boston, MA.
- Endocrine, Diabetes and Hypertension Division, Brigham and Women's Hospital, Boston, MA ; Harvard Medical School, Boston, MA.
- Department of Health Care Policy, Harvard Medical School, Boston, MA ; UMass Memorial Medical Center, University of Massachusetts, Boston, MA.
PMID: 25328637
PMCID: PMC4199332
Abstract
OBJECTIVE: Assess racial/ethnic and sex differences in treatment of vitamin D deficiency with high dose ergocalciferol ('vitamin D2') or other forms of vitamin D in a northeastern U.S. ambulatory clinic of an academic urban medical center.
STUDY DESIGN: Cross-sectional observational review of electronic medication prescribing records of patients with 25-hydroxyvitamin D (25OHD) deficiency (25OHD < 20 ng/ml) from 2004-2008.
METHODS: Using multivariable logistic regression adjusting for patients' demographics, and Elixhauser comorbidity score, we examined the association of sex and race/ethnicity with prescription for at least one dose of vitamin D.
RESULTS: Among 2,140 patients without renal disease and tested for 25OHD deficiency (25OHD < 20 ng/ml), 66.2% received no vitamin D prescription for vitamin D deficiency. Blacks and Hispanics received vitamin D prescriptions at a higher frequency than whites, 37.8% 38.4% and 30.9%, respectively, p=0.003. The vitamin D prescription rate for women versus men was 26.3% and 7.5%, respectively, p=0.04. In a fully adjusted model, no difference in prescription likelihood for blacks and whites [OR=1.18 95% CI, 0.88-1.58; p=0.29] or Hispanics and whites was noted [OR=1.01 95% CI, 0.70-1.45;p=0.73]. Similarly, fully adjusted model showed no difference in prescription likelihood for females and males [OR=1.23 95% CI, 0.93-1.63; p=0.12].
CONCLUSIONS: Among primary care patients with vitamin D deficiency, vitamin D supplementation was low and white patients were less likely to receive vitamin D treatment than blacks or Hispanics. Interventions to correct the high prevalence of vitamin D deficiency should address the markedly low rate of vitamin D prescribing when 25OHD levels are measured.
Keywords: Vitamin D; ambulatory; electronic prescribing
References
- J Natl Cancer Inst. 2008 Jun 4;100(11):826-7 - PubMed
- J Nutr Health Aging. 2008 May;12(5):291-3 - PubMed
- J Am Geriatr Soc. 2011 Jul;59(7):1165-74 - PubMed
- Bioessays. 2008 May;30(5):506-7; author reply 510-1 - PubMed
- Crit Care Med. 2011 Apr;39(4):671-7 - PubMed
- World J Pediatr. 2010 May;6(2):185; author reply 185-6 - PubMed
- J Clin Endocrinol Metab. 2012 Apr;97(4):E653-7 - PubMed
- J Clin Endocrinol Metab. 2012 Aug;97(8):2792-8 - PubMed
- J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):456-8 - PubMed
- JAMA. 2007 Nov 28;298(20):2389-98 - PubMed
- Recent Results Cancer Res. 2007;174:225-34 - PubMed
- Circ Shock. 1989 Jul;28(3):249-55 - PubMed
- Ann Intern Med. 2009 May 5;150(9):626-31 - PubMed
- Endocrinol Metab Clin North Am. 2010 Jun;39(2):287-301, table of contents - PubMed
- Med Care. 2009 Jun;47(6):626-33 - PubMed
- J Clin Endocrinol Metab. 2007 Aug;92(8):3155-7 - PubMed
- Ann Nutr Metab. 2011;59(1):38-40 - PubMed
- Epidemiol Infect. 2010 Sep;138(9):1322-7 - PubMed
- JAMA. 1999 Apr 28;281(16):1505-11 - PubMed
- J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):4-6 - PubMed
- Ann Epidemiol. 2009 Jul;19(7):468-83 - PubMed
- Eur J Obstet Gynecol Reprod Biol. 2012 Mar;161(1):18-25 - PubMed
- Am J Clin Nutr. 1991 Jul;54(1 Suppl):193S-201S - PubMed
- J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30 - PubMed
- J Nutr. 2006 Apr;136(4):1126-9 - PubMed
- Cancer Causes Control. 2008 Jun;19(5):527-35 - PubMed
- Am J Clin Nutr. 2002 Jul;76(1):187-92 - PubMed
- Int J Public Health. 2009;54(2):78-87 - PubMed
- Ann Nutr Metab. 2011 Oct;58(4):263-71 - PubMed
- Crit Care Med. 2012 Jan;40(1):63-72 - PubMed
- Sci Transl Med. 2011 Oct 12;3(104):104ra102 - PubMed
- Ann Intern Med. 2010 Jul 20;153(2):99-111 - PubMed
- Am J Clin Nutr. 2011 Dec;94(6):1471-8 - PubMed
- J Transl Med. 2009 Apr 23;7:28 - PubMed
- Osteoporos Int. 2008 Sep;19(9):1283-90 - PubMed
- BMC Public Health. 2009 Jun 18;9:191 - PubMed
- Osteoporos Int. 2010 Jul;21(7):1151-4 - PubMed
- N Engl J Med. 2007 Jul 19;357(3):266-81 - PubMed
- Arch Intern Med. 2009 Mar 23;169(6):626-32 - PubMed
- J Am Geriatr Soc. 1999 Mar;47(3):354-9 - PubMed
- J Manag Care Pharm. 2008 Sep;14(7):626-31 - PubMed
- Mil Med. 2012 Jan;177(1):70-6 - PubMed
- Am J Public Health. 2006 Feb;96(2):252-61 - PubMed
- Acad Emerg Med. 2011 May;18(5):551-4 - PubMed
- J Nutr Health Aging. 2009 Oct;13(8):700-7 - PubMed
- Curr Opin Clin Nutr Metab Care. 2011 May;14(3):291-6 - PubMed
- J Obstet Gynaecol Can. 2007 Dec;29(12):1003-1013 - PubMed
- Int J Endocrinol. 2010;2010:590751 - PubMed
- Arch Pediatr Adolesc Med. 2008 Jun;162(6):505-12 - PubMed
- Mol Nutr Food Res. 2010 Aug;54(8):1077-84 - PubMed
- Lancet. 1989 Nov 18;2(8673):1176-8 - PubMed
- J Infect Dis. 2012 Sep 15;206(6):932-42 - PubMed
- CMAJ. 2010 Sep 7;182(12):1315-9 - PubMed
- Am J Surg. 2012 Jul;204(1):37-43 - PubMed
- Pediatrics. 2010 Jun;125(6):1104-11 - PubMed
- Science. 2006 Mar 24;311(5768):1770-3 - PubMed
- J Infect. 2011 Nov;63(5):321-6 - PubMed
- N Engl J Med. 2003 Jun 26;348(26):2635-45 - PubMed
- Prog Biophys Mol Biol. 2009 Feb-Apr;99(2-3):104-13 - PubMed
- Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2467-72 - PubMed
Publication Types
Grant support